Donovan Brown

Vanderbilt University Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index69citations28works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(19), Histone Deacetylase Inhibitors Research(18), Acute Myeloid Leukemia Research(14), Cancer-related gene regulation(10), Myeloproliferative Neoplasms: Diagnosis and Treatment(5)

Publications28 total

Interallelic gene conversion of leukemia-associated single nucleotide variants
Gene·2025· 2 citedOpen Access
Repair of leukemia-associated single nucleotide variants via interallelic gene conversion
2024Open Access
Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository
Blood Advances·2024· 10 citedOpen Access
Figure S4 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S3 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Data from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Data from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S4 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S5 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S3 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S5 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation
Blood Advances·2024· 32 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Alexander J. Silver(27), Michael R. Savona(27), Haley E. Ramsey(20), Sarah D. Olmstead(20), Jackson Watke(20), Maria P. Arrate(20), Agnieszka E. Gorska(20), Andrew J. Monteith(18), Dalton Greenwood(18), Brianna N. Smith(18), Jeffrey C. Rathmell(18), Ashley D. Wise(17), Juan Liu(17), Londa Fuller(17), Jason W. Locasale(17), Matthew C. Stubbs(17), J. Brett Heimlich(7), Alexander G. Bick(7), Caitlyn Vlasschaert(5), Jessica Ulloa(5)